nodes	percent_of_prediction	percent_of_DWPC	metapath
Aripiprazole—HTR2A—phrenic nerve—amyotrophic lateral sclerosis	0.0146	0.0624	CbGeAlD
Aripiprazole—HTR3A—cranial nerve—amyotrophic lateral sclerosis	0.0094	0.0403	CbGeAlD
Aripiprazole—HTR1B—cranial nerve—amyotrophic lateral sclerosis	0.00788	0.0338	CbGeAlD
Aripiprazole—HTR1D—cranial nerve—amyotrophic lateral sclerosis	0.00763	0.0327	CbGeAlD
Aripiprazole—HTR7—cranial nerve—amyotrophic lateral sclerosis	0.00608	0.0261	CbGeAlD
Aripiprazole—HTR7—pons—amyotrophic lateral sclerosis	0.00601	0.0257	CbGeAlD
Aripiprazole—DRD1—nerve—amyotrophic lateral sclerosis	0.00499	0.0214	CbGeAlD
Aripiprazole—HTR3A—nerve—amyotrophic lateral sclerosis	0.00482	0.0206	CbGeAlD
Aripiprazole—HTR7—peripheral nervous system—amyotrophic lateral sclerosis	0.004	0.0171	CbGeAlD
Aripiprazole—HTR2A—cranial nerve—amyotrophic lateral sclerosis	0.00379	0.0162	CbGeAlD
Aripiprazole—HTR2A—pons—amyotrophic lateral sclerosis	0.00375	0.0161	CbGeAlD
Aripiprazole—Hypotonia—Riluzole—amyotrophic lateral sclerosis	0.00373	0.00552	CcSEcCtD
Aripiprazole—HTR1E—brainstem—amyotrophic lateral sclerosis	0.00367	0.0157	CbGeAlD
Aripiprazole—Anorectal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00359	0.00531	CcSEcCtD
Aripiprazole—Vulvovaginal mycotic infection—Riluzole—amyotrophic lateral sclerosis	0.00359	0.00531	CcSEcCtD
Aripiprazole—Cerebral haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00354	0.00524	CcSEcCtD
Aripiprazole—Hostility—Riluzole—amyotrophic lateral sclerosis	0.00354	0.00524	CcSEcCtD
Aripiprazole—Body temperature decreased—Riluzole—amyotrophic lateral sclerosis	0.0035	0.00518	CcSEcCtD
Aripiprazole—Hypothermia—Riluzole—amyotrophic lateral sclerosis	0.0035	0.00518	CcSEcCtD
Aripiprazole—Osteoporosis—Riluzole—amyotrophic lateral sclerosis	0.0035	0.00518	CcSEcCtD
Aripiprazole—Micturition urgency—Riluzole—amyotrophic lateral sclerosis	0.00346	0.00511	CcSEcCtD
Aripiprazole—Gingival bleeding—Riluzole—amyotrophic lateral sclerosis	0.00346	0.00511	CcSEcCtD
Aripiprazole—Suicide attempt—Riluzole—amyotrophic lateral sclerosis	0.00346	0.00511	CcSEcCtD
Aripiprazole—Cholecystitis—Riluzole—amyotrophic lateral sclerosis	0.00341	0.00505	CcSEcCtD
Aripiprazole—Completed suicide—Riluzole—amyotrophic lateral sclerosis	0.00333	0.00493	CcSEcCtD
Aripiprazole—Generalised oedema—Riluzole—amyotrophic lateral sclerosis	0.0033	0.00488	CcSEcCtD
Aripiprazole—Enlargement abdomen—Riluzole—amyotrophic lateral sclerosis	0.00326	0.00482	CcSEcCtD
Aripiprazole—Myoclonus—Riluzole—amyotrophic lateral sclerosis	0.00326	0.00482	CcSEcCtD
Aripiprazole—Polyp—Riluzole—amyotrophic lateral sclerosis	0.00322	0.00477	CcSEcCtD
Aripiprazole—Libido increased—Riluzole—amyotrophic lateral sclerosis	0.00322	0.00477	CcSEcCtD
Aripiprazole—HTR2A—hindlimb—amyotrophic lateral sclerosis	0.0032	0.0137	CbGeAlD
Aripiprazole—Blepharitis—Riluzole—amyotrophic lateral sclerosis	0.00319	0.00472	CcSEcCtD
Aripiprazole—Psoriasis—Riluzole—amyotrophic lateral sclerosis	0.00312	0.00462	CcSEcCtD
Aripiprazole—Myasthenia—Riluzole—amyotrophic lateral sclerosis	0.00312	0.00462	CcSEcCtD
Aripiprazole—HTR7—nerve—amyotrophic lateral sclerosis	0.00312	0.0134	CbGeAlD
Aripiprazole—Oral candidiasis—Riluzole—amyotrophic lateral sclerosis	0.00309	0.00457	CcSEcCtD
Aripiprazole—Respiratory distress—Riluzole—amyotrophic lateral sclerosis	0.00309	0.00457	CcSEcCtD
Aripiprazole—Calculus of kidney—Riluzole—amyotrophic lateral sclerosis	0.00299	0.00443	CcSEcCtD
Aripiprazole—Supraventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00299	0.00443	CcSEcCtD
Aripiprazole—Upset stomach—Riluzole—amyotrophic lateral sclerosis	0.00299	0.00443	CcSEcCtD
Aripiprazole—DRD2—nerve—amyotrophic lateral sclerosis	0.00295	0.0126	CbGeAlD
Aripiprazole—Cyst—Riluzole—amyotrophic lateral sclerosis	0.00293	0.00434	CcSEcCtD
Aripiprazole—ADRA2A—peripheral nervous system—amyotrophic lateral sclerosis	0.00293	0.0126	CbGeAlD
Aripiprazole—Hypokinesia—Riluzole—amyotrophic lateral sclerosis	0.0029	0.0043	CcSEcCtD
Aripiprazole—Paranoia—Riluzole—amyotrophic lateral sclerosis	0.00288	0.00426	CcSEcCtD
Aripiprazole—Seborrhoeic dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00288	0.00426	CcSEcCtD
Aripiprazole—Intestinal obstruction—Riluzole—amyotrophic lateral sclerosis	0.00288	0.00426	CcSEcCtD
Aripiprazole—Blood creatine phosphokinase increased—Riluzole—amyotrophic lateral sclerosis	0.00285	0.00422	CcSEcCtD
Aripiprazole—Haemoglobin decreased—Riluzole—amyotrophic lateral sclerosis	0.00285	0.00422	CcSEcCtD
Aripiprazole—Haematemesis—Riluzole—amyotrophic lateral sclerosis	0.00282	0.00418	CcSEcCtD
Aripiprazole—Depersonalisation—Riluzole—amyotrophic lateral sclerosis	0.0028	0.00414	CcSEcCtD
Aripiprazole—Delusion—Riluzole—amyotrophic lateral sclerosis	0.00277	0.0041	CcSEcCtD
Aripiprazole—Cyanosis—Riluzole—amyotrophic lateral sclerosis	0.00277	0.0041	CcSEcCtD
Aripiprazole—SLC6A4—hindbrain—amyotrophic lateral sclerosis	0.00275	0.0118	CbGeAlD
Aripiprazole—Apathy—Riluzole—amyotrophic lateral sclerosis	0.00274	0.00406	CcSEcCtD
Aripiprazole—HTR2A—appendage—amyotrophic lateral sclerosis	0.00274	0.0117	CbGeAlD
Aripiprazole—Laryngitis—Riluzole—amyotrophic lateral sclerosis	0.00272	0.00402	CcSEcCtD
Aripiprazole—Flat affect—Riluzole—amyotrophic lateral sclerosis	0.00272	0.00402	CcSEcCtD
Aripiprazole—Mania—Riluzole—amyotrophic lateral sclerosis	0.0027	0.00399	CcSEcCtD
Aripiprazole—Haemoptysis—Riluzole—amyotrophic lateral sclerosis	0.00265	0.00392	CcSEcCtD
Aripiprazole—Stupor—Riluzole—amyotrophic lateral sclerosis	0.00263	0.00389	CcSEcCtD
Aripiprazole—Extrapyramidal disorder—Riluzole—amyotrophic lateral sclerosis	0.0026	0.00385	CcSEcCtD
Aripiprazole—Amblyopia—Riluzole—amyotrophic lateral sclerosis	0.00254	0.00376	CcSEcCtD
Aripiprazole—Skin ulcer—Riluzole—amyotrophic lateral sclerosis	0.00252	0.00373	CcSEcCtD
Aripiprazole—HTR2A—peripheral nervous system—amyotrophic lateral sclerosis	0.00249	0.0107	CbGeAlD
Aripiprazole—HTR1A—hindbrain—amyotrophic lateral sclerosis	0.00244	0.0105	CbGeAlD
Aripiprazole—Myocardial ischaemia—Riluzole—amyotrophic lateral sclerosis	0.00244	0.00361	CcSEcCtD
Aripiprazole—Nephrolithiasis—Riluzole—amyotrophic lateral sclerosis	0.00244	0.00361	CcSEcCtD
Aripiprazole—Glycosuria—Riluzole—amyotrophic lateral sclerosis	0.00242	0.00358	CcSEcCtD
Aripiprazole—Gamma-glutamyltransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00238	0.00353	CcSEcCtD
Aripiprazole—Petechiae—Riluzole—amyotrophic lateral sclerosis	0.00238	0.00353	CcSEcCtD
Aripiprazole—H1F0—embryo—amyotrophic lateral sclerosis	0.00237	0.0101	CbGeAlD
Aripiprazole—Endocrine disorder—Riluzole—amyotrophic lateral sclerosis	0.00237	0.0035	CcSEcCtD
Aripiprazole—HTR7—hindbrain—amyotrophic lateral sclerosis	0.00233	0.01	CbGeAlD
Aripiprazole—Apnoea—Riluzole—amyotrophic lateral sclerosis	0.00231	0.00342	CcSEcCtD
Aripiprazole—Delirium—Riluzole—amyotrophic lateral sclerosis	0.00228	0.00337	CcSEcCtD
Aripiprazole—ADRA1A—hindbrain—amyotrophic lateral sclerosis	0.00225	0.00965	CbGeAlD
Aripiprazole—Breast pain—Riluzole—amyotrophic lateral sclerosis	0.00225	0.00332	CcSEcCtD
Aripiprazole—Amenorrhoea—Riluzole—amyotrophic lateral sclerosis	0.00223	0.0033	CcSEcCtD
Aripiprazole—Accidental injury—Riluzole—amyotrophic lateral sclerosis	0.00222	0.00328	CcSEcCtD
Aripiprazole—DRD2—hindbrain—amyotrophic lateral sclerosis	0.00221	0.00946	CbGeAlD
Aripiprazole—Musculoskeletal stiffness—Riluzole—amyotrophic lateral sclerosis	0.00219	0.00323	CcSEcCtD
Aripiprazole—Ventricular extrasystoles—Riluzole—amyotrophic lateral sclerosis	0.00217	0.00321	CcSEcCtD
Aripiprazole—Arthropathy—Riluzole—amyotrophic lateral sclerosis	0.00216	0.00319	CcSEcCtD
Aripiprazole—Cellulitis—Riluzole—amyotrophic lateral sclerosis	0.00216	0.00319	CcSEcCtD
Aripiprazole—Thinking abnormal—Riluzole—amyotrophic lateral sclerosis	0.00214	0.00317	CcSEcCtD
Aripiprazole—DRD1—brainstem—amyotrophic lateral sclerosis	0.00214	0.00917	CbGeAlD
Aripiprazole—Glossitis—Riluzole—amyotrophic lateral sclerosis	0.00213	0.00315	CcSEcCtD
Aripiprazole—Nocturia—Riluzole—amyotrophic lateral sclerosis	0.00211	0.00313	CcSEcCtD
Aripiprazole—Gout—Riluzole—amyotrophic lateral sclerosis	0.0021	0.00311	CcSEcCtD
Aripiprazole—Leukocytosis—Riluzole—amyotrophic lateral sclerosis	0.00209	0.00309	CcSEcCtD
Aripiprazole—Ulcer—Riluzole—amyotrophic lateral sclerosis	0.00207	0.00307	CcSEcCtD
Aripiprazole—Blood bilirubin increased—Riluzole—amyotrophic lateral sclerosis	0.00207	0.00307	CcSEcCtD
Aripiprazole—Hypercholesterolaemia—Riluzole—amyotrophic lateral sclerosis	0.00207	0.00307	CcSEcCtD
Aripiprazole—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.00207	0.00307	CcSEcCtD
Aripiprazole—HTR3A—brainstem—amyotrophic lateral sclerosis	0.00207	0.00886	CbGeAlD
Aripiprazole—Cataract—Riluzole—amyotrophic lateral sclerosis	0.00206	0.00305	CcSEcCtD
Aripiprazole—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.00201	0.00297	CcSEcCtD
Aripiprazole—Respiratory failure—Riluzole—amyotrophic lateral sclerosis	0.002	0.00295	CcSEcCtD
Aripiprazole—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.002	0.00295	CcSEcCtD
Aripiprazole—Neck pain—Riluzole—amyotrophic lateral sclerosis	0.00198	0.00294	CcSEcCtD
Aripiprazole—Ventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00196	0.0029	CcSEcCtD
Aripiprazole—Phosphatase alkaline increased—Riluzole—amyotrophic lateral sclerosis	0.00196	0.0029	CcSEcCtD
Aripiprazole—Hiccups—Riluzole—amyotrophic lateral sclerosis	0.00196	0.0029	CcSEcCtD
Aripiprazole—Pulmonary embolism—Riluzole—amyotrophic lateral sclerosis	0.00196	0.0029	CcSEcCtD
Aripiprazole—Injection site reaction—Riluzole—amyotrophic lateral sclerosis	0.00195	0.00288	CcSEcCtD
Aripiprazole—HTR2A—nerve—amyotrophic lateral sclerosis	0.00194	0.00833	CbGeAlD
Aripiprazole—Abnormal dreams—Riluzole—amyotrophic lateral sclerosis	0.00194	0.00287	CcSEcCtD
Aripiprazole—HTR1E—nervous system—amyotrophic lateral sclerosis	0.00192	0.00823	CbGeAlD
Aripiprazole—Melaena—Riluzole—amyotrophic lateral sclerosis	0.00192	0.00283	CcSEcCtD
Aripiprazole—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.00189	0.0028	CcSEcCtD
Aripiprazole—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00189	0.0028	CcSEcCtD
Aripiprazole—Candida infection—Riluzole—amyotrophic lateral sclerosis	0.00187	0.00277	CcSEcCtD
Aripiprazole—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.00186	0.00275	CcSEcCtD
Aripiprazole—HTR1E—central nervous system—amyotrophic lateral sclerosis	0.00185	0.00793	CbGeAlD
Aripiprazole—Photophobia—Riluzole—amyotrophic lateral sclerosis	0.00184	0.00272	CcSEcCtD
Aripiprazole—Coma—Riluzole—amyotrophic lateral sclerosis	0.00179	0.00265	CcSEcCtD
Aripiprazole—Neoplasm—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00262	CcSEcCtD
Aripiprazole—Ecchymosis—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00262	CcSEcCtD
Aripiprazole—Pulmonary oedema—Riluzole—amyotrophic lateral sclerosis	0.00175	0.00258	CcSEcCtD
Aripiprazole—HTR1B—brainstem—amyotrophic lateral sclerosis	0.00173	0.00743	CbGeAlD
Aripiprazole—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.00172	0.00254	CcSEcCtD
Aripiprazole—DRD4—brain—amyotrophic lateral sclerosis	0.0017	0.0073	CbGeAlD
Aripiprazole—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.0017	0.00252	CcSEcCtD
Aripiprazole—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.00168	0.00249	CcSEcCtD
Aripiprazole—CHRM4—nervous system—amyotrophic lateral sclerosis	0.00168	0.00722	CbGeAlD
Aripiprazole—HTR1D—brainstem—amyotrophic lateral sclerosis	0.00168	0.0072	CbGeAlD
Aripiprazole—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.00167	0.00247	CcSEcCtD
Aripiprazole—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.00167	0.00247	CcSEcCtD
Aripiprazole—HTR2C—brainstem—amyotrophic lateral sclerosis	0.00166	0.00713	CbGeAlD
Aripiprazole—Phlebitis—Riluzole—amyotrophic lateral sclerosis	0.00165	0.00244	CcSEcCtD
Aripiprazole—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.00164	0.00242	CcSEcCtD
Aripiprazole—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.00164	0.00242	CcSEcCtD
Aripiprazole—CHRM4—central nervous system—amyotrophic lateral sclerosis	0.00162	0.00695	CbGeAlD
Aripiprazole—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.00162	0.0024	CcSEcCtD
Aripiprazole—Deafness—Riluzole—amyotrophic lateral sclerosis	0.00159	0.00235	CcSEcCtD
Aripiprazole—Eczema—Riluzole—amyotrophic lateral sclerosis	0.00158	0.00234	CcSEcCtD
Aripiprazole—SLC6A4—brainstem—amyotrophic lateral sclerosis	0.00158	0.00676	CbGeAlD
Aripiprazole—DRD3—nervous system—amyotrophic lateral sclerosis	0.00157	0.00671	CbGeAlD
Aripiprazole—Injury—Riluzole—amyotrophic lateral sclerosis	0.00155	0.00229	CcSEcCtD
Aripiprazole—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.00153	0.00227	CcSEcCtD
Aripiprazole—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.00151	0.00224	CcSEcCtD
Aripiprazole—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.00151	0.00224	CcSEcCtD
Aripiprazole—H1F0—medulla oblongata—amyotrophic lateral sclerosis	0.00151	0.00648	CbGeAlD
Aripiprazole—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.00151	0.00223	CcSEcCtD
Aripiprazole—DRD3—central nervous system—amyotrophic lateral sclerosis	0.00151	0.00646	CbGeAlD
Aripiprazole—HTR6—nervous system—amyotrophic lateral sclerosis	0.00151	0.00646	CbGeAlD
Aripiprazole—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.0015	0.00222	CcSEcCtD
Aripiprazole—Thirst—Riluzole—amyotrophic lateral sclerosis	0.0015	0.00221	CcSEcCtD
Aripiprazole—Purpura—Riluzole—amyotrophic lateral sclerosis	0.00148	0.00218	CcSEcCtD
Aripiprazole—HTR1E—brain—amyotrophic lateral sclerosis	0.00147	0.00629	CbGeAlD
Aripiprazole—DRD5—nervous system—amyotrophic lateral sclerosis	0.00147	0.00629	CbGeAlD
Aripiprazole—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.00146	0.00217	CcSEcCtD
Aripiprazole—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.00146	0.00216	CcSEcCtD
Aripiprazole—HTR2A—hindbrain—amyotrophic lateral sclerosis	0.00146	0.00624	CbGeAlD
Aripiprazole—HTR6—central nervous system—amyotrophic lateral sclerosis	0.00145	0.00622	CbGeAlD
Aripiprazole—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.00143	0.00211	CcSEcCtD
Aripiprazole—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00142	0.00211	CcSEcCtD
Aripiprazole—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00142	0.00211	CcSEcCtD
Aripiprazole—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00142	0.00211	CcSEcCtD
Aripiprazole—DRD5—central nervous system—amyotrophic lateral sclerosis	0.00141	0.00606	CbGeAlD
Aripiprazole—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.00141	0.00209	CcSEcCtD
Aripiprazole—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.0014	0.00207	CcSEcCtD
Aripiprazole—Migraine—Riluzole—amyotrophic lateral sclerosis	0.0014	0.00207	CcSEcCtD
Aripiprazole—HTR1A—brainstem—amyotrophic lateral sclerosis	0.0014	0.006	CbGeAlD
Aripiprazole—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00139	0.00206	CcSEcCtD
Aripiprazole—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.00137	0.00203	CcSEcCtD
Aripiprazole—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.00135	0.002	CcSEcCtD
Aripiprazole—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.00135	0.002	CcSEcCtD
Aripiprazole—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.00135	0.00199	CcSEcCtD
Aripiprazole—H1F0—spinal cord—amyotrophic lateral sclerosis	0.00135	0.00578	CbGeAlD
Aripiprazole—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00134	0.00198	CcSEcCtD
Aripiprazole—HTR7—brainstem—amyotrophic lateral sclerosis	0.00134	0.00573	CbGeAlD
Aripiprazole—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.00133	0.00568	CbGeAlD
Aripiprazole—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.00132	0.00196	CcSEcCtD
Aripiprazole—CHRM5—nervous system—amyotrophic lateral sclerosis	0.00132	0.00564	CbGeAlD
Aripiprazole—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.00131	0.00194	CcSEcCtD
Aripiprazole—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.0013	0.00192	CcSEcCtD
Aripiprazole—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.0013	0.00192	CcSEcCtD
Aripiprazole—ADRA1A—brainstem—amyotrophic lateral sclerosis	0.00129	0.00553	CbGeAlD
Aripiprazole—CHRM4—brain—amyotrophic lateral sclerosis	0.00129	0.00552	CbGeAlD
Aripiprazole—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.00129	0.0019	CcSEcCtD
Aripiprazole—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00128	0.0019	CcSEcCtD
Aripiprazole—CHRM5—central nervous system—amyotrophic lateral sclerosis	0.00127	0.00543	CbGeAlD
Aripiprazole—DRD2—brainstem—amyotrophic lateral sclerosis	0.00126	0.00542	CbGeAlD
Aripiprazole—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00126	0.00186	CcSEcCtD
Aripiprazole—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00126	0.00186	CcSEcCtD
Aripiprazole—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00126	0.00186	CcSEcCtD
Aripiprazole—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00183	CcSEcCtD
Aripiprazole—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00123	0.00182	CcSEcCtD
Aripiprazole—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00123	0.00182	CcSEcCtD
Aripiprazole—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00123	0.00182	CcSEcCtD
Aripiprazole—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00121	0.00178	CcSEcCtD
Aripiprazole—ADRA1B—nervous system—amyotrophic lateral sclerosis	0.0012	0.00516	CbGeAlD
Aripiprazole—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.0012	0.00177	CcSEcCtD
Aripiprazole—DRD3—brain—amyotrophic lateral sclerosis	0.0012	0.00513	CbGeAlD
Aripiprazole—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00118	0.00174	CcSEcCtD
Aripiprazole—HTR2C—medulla oblongata—amyotrophic lateral sclerosis	0.00116	0.00497	CbGeAlD
Aripiprazole—ADRA1B—central nervous system—amyotrophic lateral sclerosis	0.00116	0.00496	CbGeAlD
Aripiprazole—HTR6—brain—amyotrophic lateral sclerosis	0.00115	0.00494	CbGeAlD
Aripiprazole—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00115	0.0017	CcSEcCtD
Aripiprazole—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.00115	0.0017	CcSEcCtD
Aripiprazole—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00114	0.00168	CcSEcCtD
Aripiprazole—H1F0—nervous system—amyotrophic lateral sclerosis	0.00114	0.00487	CbGeAlD
Aripiprazole—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00113	0.00168	CcSEcCtD
Aripiprazole—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00112	0.00166	CcSEcCtD
Aripiprazole—DRD5—brain—amyotrophic lateral sclerosis	0.00112	0.00481	CbGeAlD
Aripiprazole—DRD1—nervous system—amyotrophic lateral sclerosis	0.00112	0.00481	CbGeAlD
Aripiprazole—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00112	0.00166	CcSEcCtD
Aripiprazole—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00111	0.00165	CcSEcCtD
Aripiprazole—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.0011	0.00163	CcSEcCtD
Aripiprazole—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.0011	0.00162	CcSEcCtD
Aripiprazole—Infestation—Riluzole—amyotrophic lateral sclerosis	0.0011	0.00162	CcSEcCtD
Aripiprazole—Depression—Riluzole—amyotrophic lateral sclerosis	0.00109	0.00162	CcSEcCtD
Aripiprazole—H1F0—central nervous system—amyotrophic lateral sclerosis	0.00109	0.00469	CbGeAlD
Aripiprazole—HTR3A—nervous system—amyotrophic lateral sclerosis	0.00108	0.00464	CbGeAlD
Aripiprazole—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00108	0.0016	CcSEcCtD
Aripiprazole—DRD1—central nervous system—amyotrophic lateral sclerosis	0.00108	0.00463	CbGeAlD
Aripiprazole—HTR1B—spinal cord—amyotrophic lateral sclerosis	0.00108	0.00462	CbGeAlD
Aripiprazole—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00108	0.00159	CcSEcCtD
Aripiprazole—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00108	0.00159	CcSEcCtD
Aripiprazole—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00158	CcSEcCtD
Aripiprazole—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00158	CcSEcCtD
Aripiprazole—H1F0—cerebellum—amyotrophic lateral sclerosis	0.00107	0.00458	CbGeAlD
Aripiprazole—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00158	CcSEcCtD
Aripiprazole—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00156	CcSEcCtD
Aripiprazole—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00155	CcSEcCtD
Aripiprazole—HTR3A—central nervous system—amyotrophic lateral sclerosis	0.00104	0.00447	CbGeAlD
Aripiprazole—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00104	0.00153	CcSEcCtD
Aripiprazole—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00153	CcSEcCtD
Aripiprazole—HTR2C—spinal cord—amyotrophic lateral sclerosis	0.00103	0.00443	CbGeAlD
Aripiprazole—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00152	CcSEcCtD
Aripiprazole—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00151	CcSEcCtD
Aripiprazole—CHRM5—brain—amyotrophic lateral sclerosis	0.00101	0.00431	CbGeAlD
Aripiprazole—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.001	0.00148	CcSEcCtD
Aripiprazole—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00099	0.00146	CcSEcCtD
Aripiprazole—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.000987	0.00146	CcSEcCtD
Aripiprazole—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.000985	0.00146	CcSEcCtD
Aripiprazole—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.000985	0.00146	CcSEcCtD
Aripiprazole—SLC6A4—spinal cord—amyotrophic lateral sclerosis	0.00098	0.0042	CbGeAlD
Aripiprazole—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00098	0.00145	CcSEcCtD
Aripiprazole—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00098	0.00145	CcSEcCtD
Aripiprazole—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.000977	0.00145	CcSEcCtD
Aripiprazole—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.000972	0.00144	CcSEcCtD
Aripiprazole—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00097	0.00144	CcSEcCtD
Aripiprazole—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.000968	0.00143	CcSEcCtD
Aripiprazole—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.000965	0.00143	CcSEcCtD
Aripiprazole—HTR7—medulla oblongata—amyotrophic lateral sclerosis	0.000933	0.004	CbGeAlD
Aripiprazole—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00092	0.00136	CcSEcCtD
Aripiprazole—ADRA1B—brain—amyotrophic lateral sclerosis	0.00092	0.00394	CbGeAlD
Aripiprazole—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.000914	0.00135	CcSEcCtD
Aripiprazole—HTR2A—embryo—amyotrophic lateral sclerosis	0.00091	0.0039	CbGeAlD
Aripiprazole—HTR1B—nervous system—amyotrophic lateral sclerosis	0.000909	0.00389	CbGeAlD
Aripiprazole—CHRM2—nervous system—amyotrophic lateral sclerosis	0.000904	0.00387	CbGeAlD
Aripiprazole—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.000893	0.00132	CcSEcCtD
Aripiprazole—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.000889	0.00132	CcSEcCtD
Aripiprazole—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000887	0.00131	CcSEcCtD
Aripiprazole—Chills—Riluzole—amyotrophic lateral sclerosis	0.000883	0.00131	CcSEcCtD
Aripiprazole—HTR1D—nervous system—amyotrophic lateral sclerosis	0.00088	0.00377	CbGeAlD
Aripiprazole—HTR1B—central nervous system—amyotrophic lateral sclerosis	0.000875	0.00375	CbGeAlD
Aripiprazole—HTR2C—nervous system—amyotrophic lateral sclerosis	0.000871	0.00373	CbGeAlD
Aripiprazole—HTR1A—spinal cord—amyotrophic lateral sclerosis	0.00087	0.00373	CbGeAlD
Aripiprazole—CHRM2—central nervous system—amyotrophic lateral sclerosis	0.00087	0.00373	CbGeAlD
Aripiprazole—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00087	0.00129	CcSEcCtD
Aripiprazole—KCNH2—medulla oblongata—amyotrophic lateral sclerosis	0.000869	0.00372	CbGeAlD
Aripiprazole—H1F0—brain—amyotrophic lateral sclerosis	0.000868	0.00372	CbGeAlD
Aripiprazole—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.000863	0.00128	CcSEcCtD
Aripiprazole—ADRA2C—medulla oblongata—amyotrophic lateral sclerosis	0.000857	0.00367	CbGeAlD
Aripiprazole—DRD1—brain—amyotrophic lateral sclerosis	0.000857	0.00367	CbGeAlD
Aripiprazole—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.000857	0.00127	CcSEcCtD
Aripiprazole—ADRB1—nervous system—amyotrophic lateral sclerosis	0.000855	0.00366	CbGeAlD
Aripiprazole—HTR1D—central nervous system—amyotrophic lateral sclerosis	0.000847	0.00363	CbGeAlD
Aripiprazole—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.000845	0.00125	CcSEcCtD
Aripiprazole—Tension—Riluzole—amyotrophic lateral sclerosis	0.000841	0.00124	CcSEcCtD
Aripiprazole—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.000839	0.00124	CcSEcCtD
Aripiprazole—HTR2C—central nervous system—amyotrophic lateral sclerosis	0.000839	0.00359	CbGeAlD
Aripiprazole—HTR2A—brainstem—amyotrophic lateral sclerosis	0.000834	0.00357	CbGeAlD
Aripiprazole—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.000833	0.00123	CcSEcCtD
Aripiprazole—HTR7—spinal cord—amyotrophic lateral sclerosis	0.000832	0.00356	CbGeAlD
Aripiprazole—Back pain—Riluzole—amyotrophic lateral sclerosis	0.000829	0.00123	CcSEcCtD
Aripiprazole—HTR3A—brain—amyotrophic lateral sclerosis	0.000828	0.00355	CbGeAlD
Aripiprazole—SLC6A4—nervous system—amyotrophic lateral sclerosis	0.000826	0.00354	CbGeAlD
Aripiprazole—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.000824	0.00122	CcSEcCtD
Aripiprazole—ADRB1—central nervous system—amyotrophic lateral sclerosis	0.000823	0.00353	CbGeAlD
Aripiprazole—CHRM1—nervous system—amyotrophic lateral sclerosis	0.000823	0.00353	CbGeAlD
Aripiprazole—HTR2B—nervous system—amyotrophic lateral sclerosis	0.000818	0.00351	CbGeAlD
Aripiprazole—Tremor—Riluzole—amyotrophic lateral sclerosis	0.000803	0.00119	CcSEcCtD
Aripiprazole—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.000795	0.00118	CcSEcCtD
Aripiprazole—SLC6A4—central nervous system—amyotrophic lateral sclerosis	0.000795	0.00341	CbGeAlD
Aripiprazole—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.000792	0.00117	CcSEcCtD
Aripiprazole—CHRM1—central nervous system—amyotrophic lateral sclerosis	0.000792	0.00339	CbGeAlD
Aripiprazole—HTR2B—central nervous system—amyotrophic lateral sclerosis	0.000788	0.00338	CbGeAlD
Aripiprazole—Agitation—Riluzole—amyotrophic lateral sclerosis	0.000788	0.00117	CcSEcCtD
Aripiprazole—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.000783	0.00116	CcSEcCtD
Aripiprazole—KCNH2—spinal cord—amyotrophic lateral sclerosis	0.000775	0.00332	CbGeAlD
Aripiprazole—Malaise—Riluzole—amyotrophic lateral sclerosis	0.000773	0.00114	CcSEcCtD
Aripiprazole—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00077	0.00114	CcSEcCtD
Aripiprazole—Syncope—Riluzole—amyotrophic lateral sclerosis	0.000769	0.00114	CcSEcCtD
Aripiprazole—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.000767	0.00114	CcSEcCtD
Aripiprazole—ADRA2C—spinal cord—amyotrophic lateral sclerosis	0.000764	0.00328	CbGeAlD
Aripiprazole—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.00076	0.00326	CbGeAlD
Aripiprazole—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.000757	0.00112	CcSEcCtD
Aripiprazole—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.000753	0.00111	CcSEcCtD
Aripiprazole—Cough—Riluzole—amyotrophic lateral sclerosis	0.000748	0.00111	CcSEcCtD
Aripiprazole—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.000743	0.0011	CcSEcCtD
Aripiprazole—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00074	0.00109	CcSEcCtD
Aripiprazole—CHRM3—nervous system—amyotrophic lateral sclerosis	0.000736	0.00316	CbGeAlD
Aripiprazole—HTR1A—nervous system—amyotrophic lateral sclerosis	0.000733	0.00314	CbGeAlD
Aripiprazole—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00073	0.00108	CcSEcCtD
Aripiprazole—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00073	0.00108	CcSEcCtD
Aripiprazole—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00073	0.00108	CcSEcCtD
Aripiprazole—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.000727	0.00108	CcSEcCtD
Aripiprazole—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.000725	0.00107	CcSEcCtD
Aripiprazole—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.000721	0.00107	CcSEcCtD
Aripiprazole—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.000714	0.00106	CcSEcCtD
Aripiprazole—CHRM3—central nervous system—amyotrophic lateral sclerosis	0.000709	0.00304	CbGeAlD
Aripiprazole—HTR1A—central nervous system—amyotrophic lateral sclerosis	0.000706	0.00303	CbGeAlD
Aripiprazole—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.000705	0.00104	CcSEcCtD
Aripiprazole—HTR7—nervous system—amyotrophic lateral sclerosis	0.000701	0.003	CbGeAlD
Aripiprazole—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.0007	0.00103	CcSEcCtD
Aripiprazole—Oedema—Riluzole—amyotrophic lateral sclerosis	0.0007	0.00103	CcSEcCtD
Aripiprazole—Infection—Riluzole—amyotrophic lateral sclerosis	0.000695	0.00103	CcSEcCtD
Aripiprazole—HTR1B—brain—amyotrophic lateral sclerosis	0.000695	0.00298	CbGeAlD
Aripiprazole—CHRM2—brain—amyotrophic lateral sclerosis	0.000691	0.00296	CbGeAlD
Aripiprazole—HTR1A—cerebellum—amyotrophic lateral sclerosis	0.00069	0.00296	CbGeAlD
Aripiprazole—Shock—Riluzole—amyotrophic lateral sclerosis	0.000688	0.00102	CcSEcCtD
Aripiprazole—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.000686	0.00101	CcSEcCtD
Aripiprazole—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.000685	0.00101	CcSEcCtD
Aripiprazole—ADRA2A—medulla oblongata—amyotrophic lateral sclerosis	0.000684	0.00293	CbGeAlD
Aripiprazole—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.000683	0.00101	CcSEcCtD
Aripiprazole—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.000679	0.00101	CcSEcCtD
Aripiprazole—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.000676	0.001	CcSEcCtD
Aripiprazole—ADRA1A—nervous system—amyotrophic lateral sclerosis	0.000676	0.0029	CbGeAlD
Aripiprazole—HTR7—central nervous system—amyotrophic lateral sclerosis	0.000675	0.00289	CbGeAlD
Aripiprazole—HTR1D—brain—amyotrophic lateral sclerosis	0.000672	0.00288	CbGeAlD
Aripiprazole—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.000667	0.000987	CcSEcCtD
Aripiprazole—HTR2C—brain—amyotrophic lateral sclerosis	0.000666	0.00285	CbGeAlD
Aripiprazole—DRD2—nervous system—amyotrophic lateral sclerosis	0.000663	0.00284	CbGeAlD
Aripiprazole—HTR7—cerebellum—amyotrophic lateral sclerosis	0.000659	0.00283	CbGeAlD
Aripiprazole—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.000654	0.000967	CcSEcCtD
Aripiprazole—ADRB1—brain—amyotrophic lateral sclerosis	0.000653	0.0028	CbGeAlD
Aripiprazole—KCNH2—nervous system—amyotrophic lateral sclerosis	0.000653	0.0028	CbGeAlD
Aripiprazole—ADRA1A—central nervous system—amyotrophic lateral sclerosis	0.000651	0.00279	CbGeAlD
Aripiprazole—ADRA2C—nervous system—amyotrophic lateral sclerosis	0.000644	0.00276	CbGeAlD
Aripiprazole—DRD2—central nervous system—amyotrophic lateral sclerosis	0.000638	0.00273	CbGeAlD
Aripiprazole—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000637	0.000943	CcSEcCtD
Aripiprazole—ADRA1A—cerebellum—amyotrophic lateral sclerosis	0.000636	0.00273	CbGeAlD
Aripiprazole—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.000633	0.000936	CcSEcCtD
Aripiprazole—SLC6A4—brain—amyotrophic lateral sclerosis	0.000631	0.00271	CbGeAlD
Aripiprazole—CHRM1—brain—amyotrophic lateral sclerosis	0.000629	0.00269	CbGeAlD
Aripiprazole—KCNH2—central nervous system—amyotrophic lateral sclerosis	0.000629	0.00269	CbGeAlD
Aripiprazole—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000628	0.000929	CcSEcCtD
Aripiprazole—HTR2B—brain—amyotrophic lateral sclerosis	0.000626	0.00268	CbGeAlD
Aripiprazole—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000624	0.000923	CcSEcCtD
Aripiprazole—DRD2—cerebellum—amyotrophic lateral sclerosis	0.000623	0.00267	CbGeAlD
Aripiprazole—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.000622	0.00092	CcSEcCtD
Aripiprazole—ADRA2C—central nervous system—amyotrophic lateral sclerosis	0.00062	0.00266	CbGeAlD
Aripiprazole—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.000616	0.000911	CcSEcCtD
Aripiprazole—KCNH2—cerebellum—amyotrophic lateral sclerosis	0.000614	0.00263	CbGeAlD
Aripiprazole—ADRA2A—spinal cord—amyotrophic lateral sclerosis	0.00061	0.00261	CbGeAlD
Aripiprazole—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000608	0.0009	CcSEcCtD
Aripiprazole—ADRA2C—cerebellum—amyotrophic lateral sclerosis	0.000606	0.0026	CbGeAlD
Aripiprazole—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000604	0.000894	CcSEcCtD
Aripiprazole—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000603	0.000892	CcSEcCtD
Aripiprazole—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000598	0.000885	CcSEcCtD
Aripiprazole—Pain—Riluzole—amyotrophic lateral sclerosis	0.000598	0.000885	CcSEcCtD
Aripiprazole—ABCB1—embryo—amyotrophic lateral sclerosis	0.000596	0.00256	CbGeAlD
Aripiprazole—HTR2A—medulla oblongata—amyotrophic lateral sclerosis	0.000582	0.00249	CbGeAlD
Aripiprazole—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000576	0.000853	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000572	0.000846	CcSEcCtD
Aripiprazole—CHRM3—brain—amyotrophic lateral sclerosis	0.000563	0.00241	CbGeAlD
Aripiprazole—HTR1A—brain—amyotrophic lateral sclerosis	0.00056	0.0024	CbGeAlD
Aripiprazole—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000556	0.000822	CcSEcCtD
Aripiprazole—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000553	0.000818	CcSEcCtD
Aripiprazole—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000553	0.000818	CcSEcCtD
Aripiprazole—HTR7—brain—amyotrophic lateral sclerosis	0.000536	0.0023	CbGeAlD
Aripiprazole—HRH1—nervous system—amyotrophic lateral sclerosis	0.000523	0.00224	CbGeAlD
Aripiprazole—HTR2A—spinal cord—amyotrophic lateral sclerosis	0.000519	0.00222	CbGeAlD
Aripiprazole—ADRA1A—brain—amyotrophic lateral sclerosis	0.000517	0.00221	CbGeAlD
Aripiprazole—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000515	0.000763	CcSEcCtD
Aripiprazole—ADRA2A—nervous system—amyotrophic lateral sclerosis	0.000514	0.0022	CbGeAlD
Aripiprazole—DRD2—brain—amyotrophic lateral sclerosis	0.000506	0.00217	CbGeAlD
Aripiprazole—HRH1—central nervous system—amyotrophic lateral sclerosis	0.000504	0.00216	CbGeAlD
Aripiprazole—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000502	0.000743	CcSEcCtD
Aripiprazole—KCNH2—brain—amyotrophic lateral sclerosis	0.000499	0.00214	CbGeAlD
Aripiprazole—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000495	0.000732	CcSEcCtD
Aripiprazole—ADRA2A—central nervous system—amyotrophic lateral sclerosis	0.000495	0.00212	CbGeAlD
Aripiprazole—ADRA2C—brain—amyotrophic lateral sclerosis	0.000492	0.00211	CbGeAlD
Aripiprazole—ADRA2A—cerebellum—amyotrophic lateral sclerosis	0.000484	0.00207	CbGeAlD
Aripiprazole—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000479	0.000708	CcSEcCtD
Aripiprazole—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000463	0.000684	CcSEcCtD
Aripiprazole—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000445	0.000658	CcSEcCtD
Aripiprazole—Rash—Riluzole—amyotrophic lateral sclerosis	0.000441	0.000653	CcSEcCtD
Aripiprazole—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000441	0.000652	CcSEcCtD
Aripiprazole—Headache—Riluzole—amyotrophic lateral sclerosis	0.000438	0.000648	CcSEcCtD
Aripiprazole—HTR2A—nervous system—amyotrophic lateral sclerosis	0.000437	0.00187	CbGeAlD
Aripiprazole—HTR2A—central nervous system—amyotrophic lateral sclerosis	0.000421	0.0018	CbGeAlD
Aripiprazole—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000416	0.000615	CcSEcCtD
Aripiprazole—HTR2A—cerebellum—amyotrophic lateral sclerosis	0.000411	0.00176	CbGeAlD
Aripiprazole—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000405	0.00173	CbGeAlD
Aripiprazole—HRH1—brain—amyotrophic lateral sclerosis	0.0004	0.00171	CbGeAlD
Aripiprazole—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000398	0.00171	CbGeAlD
Aripiprazole—ADRA2A—brain—amyotrophic lateral sclerosis	0.000393	0.00168	CbGeAlD
Aripiprazole—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000389	0.00167	CbGeAlD
Aripiprazole—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.000383	0.00164	CbGeAlD
Aripiprazole—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.000381	0.00163	CbGeAlD
Aripiprazole—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000375	0.00161	CbGeAlD
Aripiprazole—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.00034	0.00146	CbGeAlD
Aripiprazole—HTR2A—brain—amyotrophic lateral sclerosis	0.000334	0.00143	CbGeAlD
Aripiprazole—CYP2D6—brain—amyotrophic lateral sclerosis	0.000304	0.0013	CbGeAlD
Aripiprazole—ABCB1—nervous system—amyotrophic lateral sclerosis	0.000286	0.00123	CbGeAlD
Aripiprazole—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.000276	0.00118	CbGeAlD
Aripiprazole—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.000269	0.00115	CbGeAlD
Aripiprazole—ABCB1—brain—amyotrophic lateral sclerosis	0.000219	0.000938	CbGeAlD
Aripiprazole—HTR2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.76e-05	0.000193	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.75e-05	0.000193	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.75e-05	0.000193	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.75e-05	0.000192	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.74e-05	0.000192	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.74e-05	0.000191	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.73e-05	0.000191	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.73e-05	0.000191	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.73e-05	0.000191	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.72e-05	0.00019	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.72e-05	0.000189	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.72e-05	0.000189	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.72e-05	0.000189	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.7e-05	0.000188	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.7e-05	0.000187	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.7e-05	0.000187	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.68e-05	0.000185	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.68e-05	0.000185	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.67e-05	0.000184	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.67e-05	0.000184	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	1.67e-05	0.000184	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.66e-05	0.000183	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.66e-05	0.000183	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.66e-05	0.000183	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.66e-05	0.000182	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.65e-05	0.000182	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.64e-05	0.000181	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.64e-05	0.00018	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.63e-05	0.00018	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.63e-05	0.000179	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.61e-05	0.000178	CbGpPWpGaD
Aripiprazole—HTR1E—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.61e-05	0.000178	CbGpPWpGaD
Aripiprazole—ADRA2A—Hemostasis—VEGFA—amyotrophic lateral sclerosis	1.6e-05	0.000177	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.6e-05	0.000177	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.6e-05	0.000176	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.6e-05	0.000176	CbGpPWpGaD
Aripiprazole—ADRA2B—Hemostasis—TP53—amyotrophic lateral sclerosis	1.6e-05	0.000176	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.6e-05	0.000176	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.59e-05	0.000176	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.58e-05	0.000174	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.58e-05	0.000174	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.58e-05	0.000174	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.56e-05	0.000172	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.56e-05	0.000172	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.55e-05	0.000171	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	1.54e-05	0.000169	CbGpPWpGaD
Aripiprazole—CYP3A7—Metabolism—APOE—amyotrophic lateral sclerosis	1.53e-05	0.000168	CbGpPWpGaD
Aripiprazole—HTR1E—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.52e-05	0.000168	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.52e-05	0.000168	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.51e-05	0.000166	CbGpPWpGaD
Aripiprazole—ADRA2C—Hemostasis—TP53—amyotrophic lateral sclerosis	1.49e-05	0.000164	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.49e-05	0.000164	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.48e-05	0.000163	CbGpPWpGaD
Aripiprazole—ADRA2C—Metabolism—APOE—amyotrophic lateral sclerosis	1.48e-05	0.000163	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.47e-05	0.000162	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.46e-05	0.000161	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.46e-05	0.000161	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.45e-05	0.00016	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.44e-05	0.000159	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.43e-05	0.000158	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.43e-05	0.000158	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.43e-05	0.000157	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.43e-05	0.000157	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.43e-05	0.000157	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.43e-05	0.000157	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.42e-05	0.000157	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.42e-05	0.000156	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.42e-05	0.000156	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.41e-05	0.000155	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.4e-05	0.000154	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.39e-05	0.000153	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.38e-05	0.000152	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.37e-05	0.000151	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.37e-05	0.000151	CbGpPWpGaD
Aripiprazole—HTR1E—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.37e-05	0.000151	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.37e-05	0.000151	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.35e-05	0.000149	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.35e-05	0.000149	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.35e-05	0.000148	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.34e-05	0.000148	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.34e-05	0.000148	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.34e-05	0.000148	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.34e-05	0.000148	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.33e-05	0.000147	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.33e-05	0.000147	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.33e-05	0.000146	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.32e-05	0.000146	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.32e-05	0.000145	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—APOE—amyotrophic lateral sclerosis	1.31e-05	0.000145	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.31e-05	0.000144	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.31e-05	0.000144	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.3e-05	0.000143	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.29e-05	0.000142	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.28e-05	0.000141	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.28e-05	0.000141	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	1.26e-05	0.000139	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.24e-05	0.000137	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.23e-05	0.000136	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.22e-05	0.000135	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.22e-05	0.000135	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.22e-05	0.000134	CbGpPWpGaD
Aripiprazole—ADRA2A—Hemostasis—TP53—amyotrophic lateral sclerosis	1.21e-05	0.000134	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.21e-05	0.000133	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.21e-05	0.000133	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—APOE—amyotrophic lateral sclerosis	1.2e-05	0.000133	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.19e-05	0.000131	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.19e-05	0.000131	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.18e-05	0.00013	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.18e-05	0.00013	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.17e-05	0.000129	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.16e-05	0.000128	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.13e-05	0.000124	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.11e-05	0.000122	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.11e-05	0.000122	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.11e-05	0.000122	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—APOE—amyotrophic lateral sclerosis	1.1e-05	0.000122	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.1e-05	0.000121	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.1e-05	0.000121	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.1e-05	0.000121	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.1e-05	0.000121	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.1e-05	0.000121	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.1e-05	0.000121	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.09e-05	0.00012	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.09e-05	0.00012	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.08e-05	0.000119	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.08e-05	0.000119	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.07e-05	0.000118	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.06e-05	0.000117	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.05e-05	0.000116	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.05e-05	0.000116	CbGpPWpGaD
Aripiprazole—CYP3A7—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.05e-05	0.000115	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.04e-05	0.000115	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.04e-05	0.000115	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.04e-05	0.000114	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.04e-05	0.000114	CbGpPWpGaD
Aripiprazole—HTR1E—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.03e-05	0.000114	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.03e-05	0.000114	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.02e-05	0.000113	CbGpPWpGaD
Aripiprazole—ADRA2C—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.02e-05	0.000112	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.01e-05	0.000112	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.01e-05	0.000111	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.01e-05	0.000111	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.01e-05	0.000111	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.01e-05	0.000111	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	9.95e-06	0.00011	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	9.95e-06	0.00011	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	9.82e-06	0.000108	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.54e-06	0.000105	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	9.5e-06	0.000105	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	9.48e-06	0.000104	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	9.4e-06	0.000104	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	9.36e-06	0.000103	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	9.35e-06	0.000103	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	9.34e-06	0.000103	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	9.3e-06	0.000102	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	9.28e-06	0.000102	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	9.15e-06	0.000101	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—TP53—amyotrophic lateral sclerosis	9.15e-06	0.000101	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	9.13e-06	0.000101	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	9.1e-06	0.0001	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	9.08e-06	0.0001	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	9.07e-06	0.0001	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—PTGS2—amyotrophic lateral sclerosis	9e-06	9.91e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	8.99e-06	9.9e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	8.96e-06	9.87e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	8.96e-06	9.87e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	8.94e-06	9.85e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	8.84e-06	9.74e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	8.82e-06	9.71e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	8.53e-06	9.4e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	8.52e-06	9.39e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	8.45e-06	9.31e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	8.44e-06	9.3e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	8.33e-06	9.18e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	8.33e-06	9.17e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.26e-06	9.1e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	8.15e-06	8.98e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	8.11e-06	8.94e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	8.06e-06	8.88e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	8.05e-06	8.86e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	7.98e-06	8.79e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	7.94e-06	8.75e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.89e-06	8.69e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	7.85e-06	8.65e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.76e-06	8.56e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	7.71e-06	8.49e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	7.67e-06	8.45e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.57e-06	8.34e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	7.46e-06	8.21e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	7.34e-06	8.08e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	7.23e-06	7.97e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	7.17e-06	7.9e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.16e-06	7.89e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—TP53—amyotrophic lateral sclerosis	7.06e-06	7.78e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—TP53—amyotrophic lateral sclerosis	7.05e-06	7.77e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.04e-06	7.76e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.03e-06	7.74e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—TP53—amyotrophic lateral sclerosis	7.01e-06	7.72e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.01e-06	7.72e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.98e-06	7.69e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.92e-06	7.62e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.92e-06	7.62e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.9e-06	7.6e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.88e-06	7.58e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.86e-06	7.56e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.79e-06	7.48e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.77e-06	7.45e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.75e-06	7.44e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.7e-06	7.38e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.66e-06	7.34e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.66e-06	7.33e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.64e-06	7.32e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.62e-06	7.29e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.6e-06	7.27e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.59e-06	7.26e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.54e-06	7.2e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.52e-06	7.18e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.45e-06	7.1e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.41e-06	7.06e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.38e-06	7.03e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.24e-06	6.87e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.08e-06	6.7e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.07e-06	6.69e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.06e-06	6.67e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6e-06	6.61e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.98e-06	6.59e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.96e-06	6.57e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.95e-06	6.55e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.93e-06	6.53e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.87e-06	6.47e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.85e-06	6.45e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.71e-06	6.29e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.47e-06	6.02e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.44e-06	5.99e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.42e-06	5.97e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.38e-06	5.93e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.23e-06	5.76e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.2e-06	5.73e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	5.13e-06	5.66e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.06e-06	5.57e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.98e-06	5.49e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.59e-06	5.06e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.52e-06	4.98e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.51e-06	4.97e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.49e-06	4.95e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.48e-06	4.93e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.43e-06	4.89e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.42e-06	4.87e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.11e-06	4.53e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.52e-06	3.88e-05	CbGpPWpGaD
